News
Christina Szperka: Member Spotlight
This month, the American Headache Society is proud to spotlight Christina Szperka, MD, MSCE, FAHS, an AHS member whose work focuses on pediatric care.
Noah Rosen, MD, FAHS: September Member Spotlight
Our September Member Spotlight is Noah Rosen, MD, FAHS. Rosen has been involved in the Refractory, Inpatient and Emergency Care Special Interest Section
OTC Migraine Treatment: Q&A
Jessica Ailani, MD, FAHS, discusses working with patients and getting honest answers about their OTC migraine treatment strategies
Member Spotlight: Andrew Russo, PhD
As our August Member Spotlight, Russo shares his passion for research and his connection to migraine
Holistic Migraine Therapies as Integrative Treatment: Q&A with Deena Kuruvilla, MD
Dr. Kuruvilla wants to remind healthcare providers that holistic therapies have a place in migraine treatment, but they should not be trusted as the sole course of action
Study Demonstrates Feasibility of Migraine-Specific CBT
Researchers in Germany showed that targeted behavioral therapies may benefit patients with migraine. Katherine Hamilton, MD, of the University of Pennsylvania, weighs-in on the results of the research.
The Maternal Migraine Link to Babies with Colic to be Unveiled at The American Headache Society 61st Annual Meeting
A leading pediatric headache expert will present data at the American Headache Society (AHS) 61st Annual Scientific Meeting that identifies a connection between mothers with migraine and babies with colic
July Member Spotlight: Manuel Vides-Rosales, MD
This month, we are spotlighting Manuel Vides-Rosales, MD, a member of the American Headache Society whose work is focused on pediatric care and language accessibility.
June Member Spotlight: Dan Henry, MD
Dr. Henry commits his career to improving the lives of those living with headache disorders
Recent Developments in Migraine and Cluster Headache Treatment
On June 4, 2019, the FDA approved galcanezumab-gnlm (Emgality®) for the treatment of episodic cluster headache in adults. This self-injection treatment was first approved by the FDA in September 2018 for the preventive treatment of migraine in adults
Study on School Start Times Shows High Schoolers with Migraine Lack Adequate Sleep
While later start times did not correlate with fewer headache days per month, teenagers with migraine are still getting ‘nowhere near’ enough sleep
Late-Life Ischemic Stroke Risk Not Associated with Early-Onset Migraine
Previous research on the connection between migraine with aura and stroke risk has been challenged by a new retrospective study of ARIC data
May Member Spotlight: Rebecca Burch, MD, FAHS
This May, we are putting the spotlight on Rebecca Burch, MD, FAHS, a member of the American Headache Society whose professional knowledge and enthusiasm for research and education have advanced the field of headache science.
Clinical Pearls on Migraine Prevention
Stephanie J. Nahas, MD, FAHS, MSEd explains how migraine prevention and patient education go hand in hand.